Colonoscopy to check for colon cancer, polyps, and adenomas.
Conditions
Interventions
Intervention group: Two groups of 72 people. The first group (Nonapick drug) was given one sachet of Nonapick (containing 16 grams of SPMC) to prepare a 150 ml solution at 2, 5 and 8 pm on the day bef
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to 65 Years
Inclusion criteria
Inclusion criteria: Adults aged 15 to 65 years who are seen on an outpatient basis for screening for colon cancer, constipation, abdominal pain, weight loss, and anemia.
Exclusion criteria
Exclusion criteria: Includes severe chronic constipation (as defined by spontaneous bowel movements less than 3 times per week), suspected intestinal perforation or obstruction, history of colon or upper gastrointestinal surgery (gastrectomy, gastric bypass), pregnancy or lactation, mental disorders, renal failure (serum creatinine greater than 1.5 times the upper limit of normal, creatinine clearance less than 30 mL/min), active inflammatory bowel disease (acute/severe/uncontrolled), congestive heart failure (class II-IV), uncontrolled hypertension, or allergies
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Colon cleansing based on the Boston Bowel Preparation Scale (BBPS) scoring standard. Timepoint: During colonoscopy. Method of measurement: The Olympus CV-190 Colonoscopy Device. | — |
Secondary
| Measure | Time frame |
|---|---|
| Includes tolerability, taste of the medication, ease of use, rate of adenoma detection (ADR), polyps, colon cancer, and side effects, and willingness to reuse. Timepoint: before and during of Colonoscopy. Method of measurement: Colonoscopy device and questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAref shiar
Babol University of Medical Sciences
Outcome results
None listed